Ho Yao - Net Worth and Insider Trading

Ho Yao Net Worth

The estimated net worth of Ho Yao is at least $63 Million dollars as of 2025-04-16. Ho Yao is the of ImmuneOnco Biopharmaceuticals (Shanghai) Inc and owns about 12,008,757 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) stock worth over $63 Million. Details can be seen in Ho Yao's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ho Yao has not made any transactions after 2023-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Ho Yao

To

Ho Yao Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ho Yao owns 1 companies in total, including ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) .

Click here to see the complete history of Ho Yao’s form 4 insider trades.

Insider Ownership Summary of Ho Yao

Ticker Comapny Transaction Date Type of Owner
HKSE:01541 ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2023-09-05

Ho Yao Latest Holdings Summary

Ho Yao currently owns a total of 1 stock. Ho Yao owns 12,008,757 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) as of September 5, 2023, with a value of $63 Million.

Latest Holdings of Ho Yao

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01541 ImmuneOnco Biopharmaceuticals (Shanghai) Inc 2023-09-05 12,008,757 5.22 62,685,712

Holding Weightings of Ho Yao


Ho Yao Form 4 Trading Tracker

According to the SEC Form 4 filings, Ho Yao has made a total of 1 transactions in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in ImmuneOnco Biopharmaceuticals (Shanghai) Inc is the sale of 0 shares on September 5, 2023, which brought Ho Yao around $0.

Insider Trading History of Ho Yao

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ho Yao Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Ho Yao Ownership Network

Ownership Network List of Ho Yao

No Data

Ownership Network Relation of Ho Yao

Insider Network Chart

Ho Yao Owned Company Details

What does ImmuneOnco Biopharmaceuticals (Shanghai) Inc do?

Who are the key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc?

Ho Yao is the of ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Other key executives at ImmuneOnco Biopharmaceuticals (Shanghai) Inc include 2501 Other Tian Wenzhi , 2201 Interest of corporation controlled by you Yu Xiaoyong , and 2101 Beneficial owner shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo .

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Insider Trades Summary

Over the past 18 months, Ho Yao made no insider transaction in ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541). Other recent insider transactions involving ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) include a net purchase of 150,000 shares made by Tian Wenzhi , a net sale of 3,165,000 shares made by shang hai zhang ke ling yi sheng fan chuang ye tou zi zhong xin you xian he huo , and a net sale of 0 shares made by Yu Xiaoyong .

In summary, during the past 3 months, insiders sold 0 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) in total and bought 150,000 shares, with a net purchase of 150,000 shares. During the past 18 months, 3,165,000 shares of ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 3,015,000 shares.

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Insider Transactions

No Available Data

Ho Yao Mailing Address

Above is the net worth, insider trading, and ownership report for Ho Yao. Currently GuruFocus does not have mailing address information for Ho Yao.